Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-07 · accession 0000899243-21-035508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-09 | 2021-09-07 | HRMY | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $8.22 | +5,000 | 5,000 | New | +$41.1K |
| D | 2021-09-09 | 2021-09-07 | HRMY | Dierks Jeffrey | Chief Commercial Off | S - Sale+OE | $37.00 | -5,000 | 0 | -100% | -$185.0K |
| DM | 2021-09-09 | 2021-09-07 | HRMY | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $0.00 | -5,000 | 23.4K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | M | A | 5,000 | $8.22 | 5,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-07 | S | D | 5,000 | $37.00 | 0 | D | — | — | |
| 3 | Derivative | Stock Option | 2021-09-07 | M | D | 4,083 | $0.00 | 7,304 | D | $8.22 · — to 2028-10-01 | 4,083 Common Stock | (F4) Reflects the exercise of 785 stock options on September 1, 2021, which was reported on the Form 4 filed by the reporting person on September 3, 2021, but erroneously reflected as an exercise of the tranche which expires on October 2, 2027, rather than the tranche which expires on October 1, 2028. (F2) The stock option is currently vested with respect to 4,868 shares, and will vest with respect to the remainder of the shares in three equal annual installments beginning on October 1, 2021. |
| 4 | Derivative | Stock Option | 2021-09-07 | M | D | 917 | $0.00 | 23,428 | D | $8.22 · — to 2030-03-04 | 917 Common Stock | (F3) The stock option is currently vested with respect to 4,869 shares, and will vest with respect to the remainder of the shares in four equal annual installments beginning on March 1, 2022. |